Showing results (291-300 of 513) with videos related to
Sort By:
Pageof 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
The First-week Proliferative Response of Peripheral Blood PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts the Response to Anti-PD-1 Therapy in Solid TumorsKyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, et al.The Lancet. Oncology|July 21, 2009
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trialMartin E Gore, Cezary Szczylik, Camillo Porta, et al.Cancer Research and Treatment|January 24, 2014
Clinical Implications of VEGF, TGF-β1, and IL-1β in Patients with Advanced Non-small Cell Lung CancerJi-Won Kim, Youngil Koh, Dong-Wan Kim, et al.Japanese Journal of Clinical Oncology|September 7, 2012
The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib useYoungil Koh, Hee Eun Lee, Do-Youn Oh, et al.Scientific Reports|May 28, 2024
Selecting serum-free hepatocyte cryopreservation stage and storage temperature for the application of an "off-the-shelf" bioartificial liver systemJi-Hyun Lee, Hey-Jung Park, Young-A Kim, et al.Journal for Immunotherapy of Cancer|May 18, 2019
Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinomaSehhoon Park, Je-Gun Joung, Yang Won Min, et al.Neuro-Oncology Practice|August 7, 2019
Early cognitive function tests predict early progression in glioblastomaSoon-Tae Lee, Chul-Kee Park, Jin Wook Kim, et al.Cancer|December 6, 2012
Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphomaTae Min Kim, Jin Chul Paeng, In Kook Chun, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trialSung Won Lim, Sehhoon Park, Youjin Kim, et al.JCO Precision Oncology|September 11, 2020
Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA-Guided Therapy in Refractory Metastatic Solid Cancers: An Interim AnalysisSeung Tae Kim, Kimberly C Banks, Se-Hoon Lee, et al.Pageof 52